Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 9/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.40 |
| ▸ | NCOR2 | Q9Y618 | 6/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6201094 | 0.81 | MAPT (0.52) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL7741393 | 0.81 | CYP1A2 (0.42) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL29922638 | 0.81 | CYP1A2 (0.42) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL7375160 | 0.78 | KDM4E (0.49) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL30128490 | 0.78 | KDM4E (0.49) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL215272 | 0.77 | HDAC3 (0.50) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL867417 | 0.77 | PRSS1 (0.47) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL3151717 | 0.77 | MAPT (0.67) | MAPTKDM4EGAAMEN1ALDH1A1 | |
| SCHEMBL29922627 | 0.77 | MAPT (0.37) | HDAC3HDAC1HDAC2NCOR2HDAC10 | |
| SCHEMBL21799927 | 0.77 | MAPT (0.37) | HDAC3HDAC1HDAC2NCOR2HDAC10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102093156-B | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | GEN ELECTRIC | 2013-09-18 | — | — | CN | disclosed |
| CN-102093156-A | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | GEN ELECTRIC | 2011-06-15 | — | — | CN | disclosed |
| US-20090032768-A1 | WATER-SOLUBLE PHENYLENEDIAMINE COMPOSITIONS AND METHODS FOR STABILIZING ETHYLENICALLY UNSATURATED COMPOUNDS AND MONOMERS | GENERAL ELECTRIC COMPANY (US) | 2009-02-05 | — | — | US | disclosed |
| US-7414162-B2 | For inhibiting polymerization of ethylenically unsaturated monomers; includes a water-soluble phenylenediamine composition | GENERAL ELECTRIC COMPANY (US) | 2008-08-19 | — | — | US | disclosed |
| US-20070187649-A1 | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | GENERAL ELECTRIC COMPANY | 2007-08-16 | — | — | US | disclosed |
| CN-1813040-A | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | GEN ELECTRIC (US) | 2006-08-02 | — | — | CN | disclosed |
| EP-1620526-A1 | WATER-SOLUBLE PHENYLENEDIAMINE COMPOSITIONS AND METHODS FOR STABILIZING ETHYLENICALLY UNSATURATED COMPOUNDS AND MONOMERS | GENERAL ELECTRIC COMPANY (US) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004096951-A1 | WATER-SOLUBLE PHENYLENEDIAMINE COMPOSITIONS AND METHODS FOR STABILIZING ETHYLENICALLY UNSATURATED COMPOUNDS AND MONOMERS | GENERAL ELECTRIC COMPANY (US) | 2004-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070187649-A1 | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | PNMT, EPN1, FASN | HDAC3 4824/4885HDAC1 4579/4885HDAC2 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.